title: Ketamine alters oscillatory coupling in the hippocampus.
abstract: Recent studies show that higher order oscillatory interactions such as cross-frequency coupling are important for brain functions that are impaired in schizophrenia, including perception, attention and memory. Here we investigated the dynamics of oscillatory coupling in the hippocampus of awake rats upon NMDA receptor blockade by ketamine, a pharmacological model of schizophrenia. Ketamine (25, 50 and 75 mg/kg i.p.) increased gamma and high-frequency oscillations (HFO) in all depths of the CA1-dentate axis, while theta power changes depended on anatomical location and were independent of a transient increase of delta oscillations. Phase coherence of gamma and HFO increased across hippocampal layers. Phase-amplitude coupling between theta and fast oscillations was markedly altered in a dose-dependent manner: ketamine increased hippocampal theta-HFO coupling at all doses, while theta-gamma coupling increased at the lowest dose and was disrupted at the highest dose. Our results demonstrate that ketamine alters network interactions that underlie cognitively relevant theta-gamma coupling.
authors.affiliation: Brain Institute, Federal University of Rio Grande do Norte, Natal, RN 59056-450, Brazil.
authors.forename: Fábio V
authors.initials: FV
authors.lastname: Caixeta
authors.forename: Alianda M
authors.initials: AM
authors.lastname: Cornélio
authors.forename: Robson
authors.initials: R
authors.lastname: Scheffer-Teixeira
authors.forename: Sidarta
authors.initials: S
authors.lastname: Ribeiro
authors.forename: Adriano B L
authors.initials: AB
authors.lastname: Tort
mesh_terms: D000818:Animals; D001683:Biological Clocks / Q000187:drug effects / Q000502:physiology*; D058256:Brain Waves / Q000187:drug effects / Q000502:physiology*; D004305:Dose-Response Relationship, Drug; D006624:Hippocampus / Q000187:drug effects / Q000502:physiology*; D007649:Ketamine / Q000008:administration & dosage*; D008297:Male; D009415:Nerve Net / Q000187:drug effects / Q000502:physiology*; D009434:Neural Pathways / Q000187:drug effects / Q000502:physiology; D051381:Rats; D017208:Rats, Wistar; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors*
chemical_list: D016194:Receptors, N-Methyl-D-Aspartate; D007649:Ketamine
references.citation: Nat Neurosci. 2010 Jan;13(1):76-83
references.pmid: 19915563
references.citation: J Neurosci Methods. 2006 Oct 15;157(1):91-7
references.pmid: 16701901
references.citation: Front Hum Neurosci. 2012 Jan 13;5:190
references.pmid: 22319485
references.citation: J Neurosci. 1995 Jan;15(1 Pt 1):47-60
references.pmid: 7823151
references.citation: J Neurophysiol. 2013 Jan;109(2):570-9
references.pmid: 23114214
references.citation: Cereb Cortex. 2012 Oct;22(10):2404-14
references.pmid: 22079925
references.citation: Prog Neurobiol. 2013 Jan;100:1-14
references.pmid: 23022096
references.citation: Schizophr Res. 2006 Apr;83(2-3):111-9
references.pmid: 16524699
references.citation: J Neurophysiol. 2010 Aug;104(2):1195-210
references.pmid: 20463205
references.citation: Eur Neuropsychopharmacol. 1997 Feb;7(1):9-24
references.pmid: 9088881
references.citation: Brain Struct Funct. 2012 Apr;217(2):395-409
references.pmid: 21979451
references.citation: Biol Psychiatry. 2012 May 15;71(10):873-80
references.pmid: 22361076
references.citation: Schizophr Res. 2008 Oct;105(1-3):262-71
references.pmid: 18603413
references.citation: Proc Natl Acad Sci U S A. 2008 Dec 23;105(51):20517-22
references.pmid: 19074268
references.citation: Schizophr Bull. 2012 Jan;38(1):9-14
references.pmid: 21965469
references.citation: PLoS One. 2011;6(12):e28489
references.pmid: 22163023
references.citation: J Neurosci. 2011 Aug 10;31(32):11733-43
references.pmid: 21832203
references.citation: Neuropharmacology. 2012 Mar;62(3):1574-83
references.pmid: 21277876
references.citation: Nat Rev Neurosci. 2001 Oct;2(10):704-16
references.pmid: 11584308
references.citation: Schizophr Bull. 2011 Jul;37(4):659-63
references.pmid: 21653278
references.citation: Mol Psychiatry. 2012 May;17(5):537-48
references.pmid: 21468034
references.citation: Proc Natl Acad Sci U S A. 2004 Dec 7;101(49):17288-93
references.pmid: 15546988
references.citation: Anesthesiology. 1973 Oct;39(4):370-6
references.pmid: 4758343
references.citation: Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3561-6
references.pmid: 19204281
references.citation: Biol Psychiatry. 2012 Jun 1;71(11):987-95
references.pmid: 22055014
references.citation: Nat Med. 2006 Jul;12(7):824-8
references.pmid: 16767099
references.citation: Neuron. 2010 Nov 4;68(3):557-69
references.pmid: 21040854
references.citation: Prog Neurobiol. 2007 Mar;81(4):237-50
references.pmid: 17350744
references.citation: Nat Rev Neurosci. 2010 Feb;11(2):100-13
references.pmid: 20087360
references.citation: Int J Neuropsychopharmacol. 2012 Jun;15(5):657-68
references.pmid: 21733235
references.citation: J Nerv Ment Dis. 1991 Jan;179(1):12-7; discussion 18
references.pmid: 1985143
references.citation: Science. 2004 Jun 25;304(5679):1926-9
references.pmid: 15218136
references.citation: Neuron. 2002 Jan 31;33(3):325-40
references.pmid: 11832222
references.citation: J Neurosci. 2013 Jan 23;33(4):1535-9
references.pmid: 23345227
references.citation: J Neurophysiol. 2012 Jun;107(11):3181-9
references.pmid: 22423006
references.citation: Behav Brain Res. 2000 Jun 15;111(1-2):1-11
references.pmid: 10840127
references.citation: Nat Neurosci. 2012 Nov;15(11):1524-30
references.pmid: 23042082
references.citation: PLoS One. 2009 Aug 25;4(8):e6755
references.pmid: 19707548
references.citation: J Neurosci Methods. 2008 May 30;170(2):352-7
references.pmid: 18328571
references.citation: Schizophr Bull. 1998;24(2):267-83
references.pmid: 9613625
references.citation: Neuron. 2006 Oct 5;52(1):155-68
references.pmid: 17015233
references.citation: J Neurosci. 1997 Apr 15;17(8):2921-7
references.pmid: 9092613
references.citation: J Cogn Neurosci. 2010 Jul;22(7):1452-64
references.pmid: 19583475
references.citation: Biol Psychiatry. 2008 Apr 15;63(8):730-5
references.pmid: 18022604
references.citation: Psychopharmacology (Berl). 2004 Jun;174(1):151-62
references.pmid: 15205886
references.citation: PLoS One. 2011;6(7):e21814
references.pmid: 21829443
references.citation: Neuron. 2008 Nov 26;60(4):683-97
references.pmid: 19038224
references.citation: J Neurosci. 2003 Jun 1;23(11):4726-36
references.pmid: 12805312
references.citation: Proc Natl Acad Sci U S A. 2007 Aug 14;104(33):13490-5
references.pmid: 17679692
references.citation: Neuropsychopharmacology. 2001 Oct;25(4):455-67
references.pmid: 11557159
references.citation: Trends Cogn Sci. 2010 Nov;14(11):506-15
references.pmid: 20932795
references.citation: Proc Natl Acad Sci U S A. 2009 Dec 8;106(49):20942-7
references.pmid: 19934062
references.citation: Biol Psychiatry. 2006 Dec 1;60(11):1231-40
references.pmid: 16893524
references.citation: Schizophr Bull. 2008 Sep;34(5):974-80
references.pmid: 18559405
references.citation: Arch Gen Psychiatry. 1994 Mar;51(3):199-214
references.pmid: 8122957
references.citation: Biol Psychiatry. 2006 Dec 1;60(11):1206-14
references.pmid: 16650831
references.citation: Lab Anim. 1981 Apr;15(2):163-70
references.pmid: 7278122
references.citation: Trends Cogn Sci. 2007 Jul;11(7):267-9
references.pmid: 17548233